YBX1 and cancer: In this regard, the YBX1 protein has been shown to be overexpressed in cancer cells resistant to cisplatin therapy [136], and in a recent study, YBX1 has been shown to mediate sensitivity to cisplatin in a xenograft model of NSCLC [137].